BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2.04 Cr | ₹-6.41 Cr | ₹7.64 Cr | ₹-1.63 Cr | ₹-6.68 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BAFNA PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹2.04 Cr |
| Mar2024 | ₹-6.41 Cr |
| Mar2023 | ₹7.64 Cr |
| Mar2022 | ₹-1.63 Cr |
| Mar2021 | ₹-6.68 Cr |
How is Net Cash Inflow / Outflow of BAFNA PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.04 Cr | Positive | |
| Mar2024 | ₹-6.41 Cr | Negative | |
| Mar2023 | ₹7.64 Cr | Positive | |
| Mar2022 | ₹-1.63 Cr | Negative | |
| Mar2021 | ₹-6.68 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹304.7 Cr | -10% | -15.4% | 54.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -10% |
-15.4% |
54.1% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses